Page last updated: 2024-10-21

phenytoin and Ornithine Carbamoyltransferase Deficiency Disease

phenytoin has been researched along with Ornithine Carbamoyltransferase Deficiency Disease in 2 studies

Ornithine Carbamoyltransferase Deficiency Disease: An inherited urea cycle disorder associated with deficiency of the enzyme ORNITHINE CARBAMOYLTRANSFERASE, transmitted as an X-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. (Menkes, Textbook of Child Neurology, 5th ed, pp49-50)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strom, SC1
Fisher, RA1
Rubinstein, WS1
Barranger, JA1
Towbin, RB1
Charron, M1
Mieles, L1
Pisarov, LA1
Dorko, K1
Thompson, MT1
Reyes, J1
Lipson, A1
Bale, P1

Other Studies

2 other studies available for phenytoin and Ornithine Carbamoyltransferase Deficiency Disease

ArticleYear
Transplantation of human hepatocytes.
    Transplantation proceedings, 1997, Volume: 29, Issue:4

    Topics: Adolescent; Adult; Cell Culture Techniques; Cell Transplantation; Child, Preschool; Female; Hepatic

1997
Ependymoblastoma associated with prenatal exposure to diphenylhydantoin and methylphenobarbitone.
    Cancer, 1985, May-01, Volume: 55, Issue:9

    Topics: Brain Neoplasms; Child, Preschool; Ependymoma; Female; Frontal Lobe; Heterozygote; Humans; Maternal-

1985